Submit your research today!

About the special issue

New materials and manufacturing techniques are emerging with the potential to address the challenges associated with the manufacture of pharmaceutical systems that will teach new tricks to old drugs and on the development of new personalized medical devices. Current medical developments are aiming to achieve personalized medicine adapted to patients’ needs. Moreover, technological advances in healthcare must continually develop to ensure that the world is prepared for any future diseases that may ensue. In this context, biofabrication (e.g., Bioprinting, Electrowriting / Melt electrospinning) and Additive manufacturing methods (e.g., 3D & 4D printing), allow for a patient-centered approach. Scaffolds, patches, long-acting implantable devices, microneedles, and oral films, among many others, have been successfully manufactured; however, some challenges must be overcome to shift to clinical practice.

With this special issue, we are planning to cover the recent advantages and future directions on 3D printing, Bioprinting and electrowriting methods, for the production of drug delivery systems.The issue welcomes authors to submit relevant editorials, reviews, technology evaluations, interviews, and original research. The benefit of publishing as part of a special issue is that the articles included often receive more views and higher citation numbers.

If you are interested in contributing or would like to learn more, then please reach out to the Guest Advisor, Prof Dimitrios Lamprou, and the Commissioning Editor, Zoe Kenney, with an abstract.

About the Guest Advisor:

Dimitrios Lamprou (Ph.D., MBA) is Full Professor (Chair) of Biofabrication and Advanced Manufacturing, and Director at MSc Industrial Pharmaceutics at Queen’s University Belfast. He is also the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS) and the Chair of the Academy of Pharmaceutical Sciences (APS) Emerging Technologies Focus Group. Dimitrios, is the author of over 150 peer-reviewed publications, has over 350 conference abstracts, has given over 150 Invited Talks in institutions and conferences across the world, and has secured funding more than £3M. Dimitrios has been recognised as world leader in 3D Printing & Microfluidics. PubMed-based algorithms placed him in the top 0.088% of scholars in the world writing about 3D Printing and on the top 0.071% of scholars in the world writing about microfluidics, in the past 10-years. Moreover, PubMed-based algorithms placed him in the top 0.63% of scholars writing about nanofibers. Dimitrios has also been named in the Stanford University’s list 2021 & 2022 of World’s Top 2% Scientists, for his research in Pharmaceutics and Biomedical Engineering. His research and academic leadership have been recognized in a range of awards, including the Royal Pharmaceutical Society Science Award and the Scottish Universities Life Sciences Alliance Leaders Scheme Award. For more info, please visit www.emergingtechnologieslab.com.

Publish in 3 – 5 weeks from submission

Submission to acceptance: 2 – 3 weeks
1 – 2 weeks for peer review
1 week for author revision

Acceptance to online publication: 1 – 2 weeks, with proofs within 5 working days and 48 hours for author review

Cost per article: $7000 / €6200 / £5500

Publish in 7 – 9 weeks from submission

Submission to acceptance: 5 – 6 weeks
3 – 4 weeks for peer review
2 weeks for author revision

Acceptance to online publication: 2 – 3 weeks, with proofs within 10 working days

Cost per article: $3900 / €3400 / £3000